Spiral Therapeutics Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$27.1M
- Investors
-
14
Spiral Therapeutics General Information
Description
Developer of drug therapies designed to treat inner ear disorders. The company offers therapies targeting acute and subacute hearing loss and balance conditions, enabling patients to access treatment options for the prevention and management of hearing loss.
Contact Information
Website
www.spiraltx.comCorporate Office
- 6000 Shoreline Court
- Suite 206
- South San Francisco, CA 94080
- United States
Corporate Office
- 6000 Shoreline Court
- Suite 206
- South San Francisco, CA 94080
- United States
Spiral Therapeutics Timeline
Spiral Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series B) | 14-Apr-2026 | $27.1M | Completed | Startup | ||
| 4. Secondary Transaction - Private | Completed | Clinical Trials - Phase 2 | ||||
| 3. Later Stage VC (Series A) | 07-Feb-2023 | Completed | Clinical Trials - Phase 2 | |||
| 2. Early Stage VC (Series A) | 05-May-2019 | $10.2M | $13.2M | Completed | Clinical Trials - Phase 2 | |
| 1. Early Stage VC (Series A2) | 31-Dec-2016 | $3M | $3M | Completed | Startup |
Spiral Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-3 | ||||||||
| Series B-2 | ||||||||
| Series B-1 | ||||||||
| Series A5 | ||||||||
| Series A4 | ||||||||
| Series A3 | ||||||||
| Series A2 | 3,080,869 | $0.000100 | 8% | $1.03 | $1.03 | 1x | $1.03 | 2.53% |
| Series A1 | 2,565,443 | $0.000100 | 8% | $2.16 | $2.16 | 1x | $2.16 | 2.11% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Spiral Therapeutics Comparisons
Industry
Financing
Details
Spiral Therapeutics Competitors (8)
One of Spiral Therapeutics’s 8 competitors is Otologic Pharmaceutics, a Formerly VC-backed company based in Oklahoma City, OK.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Otologic Pharmaceutics | Formerly VC-backed | Oklahoma City, OK | ||||
| Acousia Therapeutics | Venture Capital-Backed | Tubingen, Germany | ||||
| Akouos | Formerly VC-backed | Boston, MA | ||||
| Audion Therapeutics | Venture Capital-Backed | Amsterdam, Netherlands | ||||
| Sound Pharmaceuticals | Venture Capital-Backed | Seattle, WA |
Spiral Therapeutics Patents
Spiral Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12728245-B2 | System for accessing a cochlear implant lead insertion site | Active | 26-Sep-2024 | ||
| US-20260097191-A1 | System for accessing a cochlear implant lead insertion site | Pending | 26-Sep-2024 | ||
| US-20260102594-A1 | System for accessing a cochlear implant lead insertion site | Active | 26-Sep-2024 | ||
| US-20260102596-A1 | System for accessing a cochlear implant lead insertion site | Pending | 26-Sep-2024 | ||
| US-20260108714-A1 | System for accessing a cochlear implant lead insertion site | Pending | 26-Sep-2024 | A61M39/10 |
Spiral Therapeutics Signals
Spiral Therapeutics Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Advanced Bionics | Corporation | Minority | ||
| Esperante Ventures | Corporate Venture Capital | Minority | ||
| Gund Investment (Mongolia) | Limited Partner | Minority | ||
| Pebble Accelerator | Venture Capital | Minority | ||
| Uni-Bio Science | Corporation | Minority |
Spiral Therapeutics Investments (2)
Spiral Therapeutics’s most recent deal was a Corporate Asset Purchase with Otonomy (Certain Assets) for . The deal was made on 29-Mar-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Otonomy (Certain Assets) | 29-Mar-2023 | Corporate Asset Purchase | Buildings and Property | ||
| Agatha | 03-Nov-2021 | Later Stage VC | Enterprise Systems (Healthcare) |
Spiral Therapeutics FAQs
-
When was Spiral Therapeutics founded?
Spiral Therapeutics was founded in 2016.
-
Where is Spiral Therapeutics headquartered?
Spiral Therapeutics is headquartered in South San Francisco, CA.
-
What is the size of Spiral Therapeutics?
Spiral Therapeutics has 10 total employees.
-
What industry is Spiral Therapeutics in?
Spiral Therapeutics’s primary industry is Drug Discovery.
-
Is Spiral Therapeutics a private or public company?
Spiral Therapeutics is a Private company.
-
What is the current valuation of Spiral Therapeutics?
The current valuation of Spiral Therapeutics is .
-
What is Spiral Therapeutics’s current revenue?
The current revenue for Spiral Therapeutics is .
-
How much funding has Spiral Therapeutics raised over time?
Spiral Therapeutics has raised $51.2M.
-
Who are Spiral Therapeutics’s investors?
Advanced Bionics, Esperante Ventures, Gund Investment (Mongolia), Pebble Accelerator, and Uni-Bio Science are 5 of 14 investors who have invested in Spiral Therapeutics.
-
Who are Spiral Therapeutics’s competitors?
Otologic Pharmaceutics, Acousia Therapeutics, Akouos, Audion Therapeutics, and Sound Pharmaceuticals are some of the 8 competitors of Spiral Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process